- Munson (2002) recommends computed tomography (CT) and magnetic resonance imaging
(MRI) studies of the brain. Most inhalants contain solvents, which target and
dissolve fatty tissue in the brain, liver, kidneys and adrenal glands. According
to Munson (2002) new research suggests inhalants may dissolve the myelin sheath
of neurons in the brain.
- Inhalants are not detected
by routine drug screens, but a routine drug screen is recommended to rule
out other drugs. Laboratory identification of inhalant abuse most often requires
analysis of body fluids by gas chromatography.
- A complete blood count
(CBC) should be performed to determine if infection or anemia are present.
- Creatinine, blood urea
nitrogen (BUN) and urinalysis to assess kidney function should be included
in the workup.
- Broussard (2000) recommends also obtaining electrolytes, phosphorous, and calcium
levels, an acid-base assessment, hepatic and renal profiles, and cardiac/muscle
- Electrocardiogram (ECG)
and chest x-ray should be used to determine heart and lung damage.
- Visual and auditory-evoked
potentials are abnormal in children who have significant abuse history.
- Neuropsychologic testing